Asia/Oceania
Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project
The firm will provide testing using its HCCscreen assay and help develop follow-up procedures as part of an effort to advance cancer early detection in rural areas of China.
Micronoma, University of New South Wales to Develop Liver Cancer Dx Using $4M Grant
University researchers will use the firm's platform to analyze microbiome biomarkers to develop a noninvasive early detection method for hepatocellular carcinoma.
GenesisCare Takes Minority Stake in Precision Medicine Firm PreludeDx
Earlier this year, the companies signed a deal to expand access to PreludeDx's DCISionRT precision medicine breast cancer test in Australia and the US.
Korean AI Pathology Startup Lunit Nabs $26M Investment from Guardant Health; Plans Collaboration
Having closed a Series C funding round, the firm is completing clinical validation, and will collaborate with Guardant to develop new precision oncology products.
Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA for $4M
EasyDNA sells a range of paternity, oncology, animal genomics, and health and wellness genetic tests through 12 agreements with labs across the world.